Rodman & Renshaw Starts CorMedix (CRMD) at Buy
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Price: $7.80 -4.18%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Rodman & Renshaw analyst Brandon Folkes initiates coverage on CorMedix (NASDAQ: CRMD) with a Buy rating and a price target of $13.00.
For an analyst ratings summary and ratings history on CorMedix click here. For more ratings news on CorMedix click here.
Shares of CorMedix closed at $5.65 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- H.C. Wainwright Reiterates Buy Rating on CorMedix (CRMD)
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
